Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
NOVO ALLE DK 2880, BAGSVAERD DENMARK, G7
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
22 Jun 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Novo Nordisk A/S.

10 Apr 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Novo Nordisk A/S.

5 Mar 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Novo Nordisk A/S.

21 Oct 2025

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Novo Nordisk A/S.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Verified Capital Structure Unavailable
Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Neutral
Target: $42.53
8.9% upside potential
📈
Strong Buy
Unavailable
👍
Buy
0
⏸️
Hold
5
📉
Sell
1
6 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 40.00–47.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
Verified Insider Transactions Unavailable
Director and insider transaction data is not ingested for this stock yet.

Top Shareholders

Dodge & Cox
20,397,110 shares
5.5% change
6/30/2026
Loomis Sayles & Co L P
18,594,352 shares
9.267% change
6/30/2026
Franklin Templeton Inc
13,041,109 shares
-18.916% change
6/30/2026
Price T Rowe Associates Inc /Md/
11,704,719 shares
5.823% change
6/30/2026
Morgan Stanley
11,659,869 shares
7.274% change
6/30/2026
Bank Of America Corp /De/
11,176,712 shares
3.779% change
6/30/2026
Capital International Investors
9,721,180 shares
-17.588% change
6/30/2026
Folketrygdfondet
9,522,383 shares
4.863% change
6/30/2026
Goldman Sachs Group Inc
9,180,490 shares
79.27% change
6/30/2026
Fisher Asset Management, Llc
8,324,948 shares
-7.717% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 5 hours ago